Sham Tung Ting, Zhang Huan, Mok Daniel Kam Wah, Chan Shun Wan, Wu Jianhong, Tang Songyun, Chan Chi On
Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Hong Kong, China.
State Key Laboratory of Chinese Medicine and Molecular Pharmacology (Incubation), Shenzhen 518057, China.
Antioxidants (Basel). 2017 Jul 21;6(3):57. doi: 10.3390/antiox6030057.
The hypocholesterolemic protective effect of the dried seed of (ACS) was investigated in rats fed with normal diet, high cholesterol diet (HCD), and HCD plus 70% ethanol extract of ACS (600 mg/kg/day) by oral gavage for four weeks. ACS extract was tested to be rich in antioxidants, which may be contributed to its high content of phenolic compounds. Consumption of ACS remarkably suppressed the elevated total cholesterol ( < 0.01) and LDL-C ( < 0.001) induced by HCD. Chemical constituents of ACS extract were analyzed by ultra-performance liquid chromatography coupled with electrospray ionization orbitrap mass spectrometry and the results showed that the ACS extract mainly consisted of phenolic compounds including flavonoids and flavonoid glycosides. In addition, based on the serum fatty acid profiles, elucidated using gas chromatography-mass spectrometry, free and esterified fatty acids including docosapentaenoic acid, adrenic acid, dihomo-γ-linolenic acid and arachidonic acid were regulated in ACS treatment group. Western blot results further indicated the protein expression of peroxisome proliferator-activated receptor alpha (PPARα) ( < 0.05) in liver was upregulated in ACS treatment group. To conclude, our results clearly demonstrated that ACS provides beneficial effect on lowering HCD associated detrimental change.
研究了[植物名称]干燥种子(ACS)对正常饮食、高胆固醇饮食(HCD)以及通过口服灌胃给予HCD加ACS 70%乙醇提取物(600毫克/千克/天)四周的大鼠的降胆固醇保护作用。经测试,ACS提取物富含抗氧化剂,这可能归因于其高含量的酚类化合物。食用ACS可显著抑制由HCD诱导的总胆固醇升高(P<0.01)和低密度脂蛋白胆固醇升高(P<0.001)。采用超高效液相色谱-电喷雾电离轨道阱质谱联用技术分析了ACS提取物的化学成分,结果表明ACS提取物主要由酚类化合物组成,包括黄酮类化合物和黄酮糖苷。此外,基于气相色谱-质谱联用技术阐明的血清脂肪酸谱,ACS治疗组中包括二十二碳五烯酸、肾上腺酸、二高-γ-亚麻酸和花生四烯酸在内的游离脂肪酸和酯化脂肪酸得到了调节。蛋白质印迹结果进一步表明,ACS治疗组肝脏中过氧化物酶体增殖物激活受体α(PPARα)的蛋白表达上调(P<0.05)。总之,我们的结果清楚地表明,ACS对降低与HCD相关的有害变化具有有益作用。